PATIENT SUPPORT PROGRAM
3B Biotech partners with you to assess needs and design cost-effective Patient Support Programs (PSPs).
We ensure full compliance with the pharmacovigilance requirements associated with PSPs, in accordance with applicable legislation.We ensure full compliance with the pharmacovigilance requirements associated with PSPs, in accordance with applicable legislation.
In a constantly evolving healthcare environment, where patients have increasing access to information about their conditions and treatment options, Patient Support Programs (PSPs) play an essential role in improving the diagnostic and therapeutic journey while addressing individual patients’ needs and expectations.
Designing and delivering PSPs is essential to help patients follow their treatment correctly, reduce travel away from home and make better use of healthcare resources.
3B Biotech partners with you to assess needs and design cost-effective PSPs.
3B Biotech also ensures compliance with pharmacovigilance requirements associated with PSPs, in accordance with local and European legislation.
Module VI of Good Pharmacovigilance Practices (GVP) addresses the legal requirements applicable to stakeholders for the collection, management and reporting of suspected adverse reactions to medicinal products for human use authorised in the European Union (EU). It also sets out requirements for Marketing Authorisation Holders (MAHs) concerning the management and reporting of safety data arising from PSPs.
Serious and non-serious cases of suspected adverse reactions arising from these programs should be reported by MAHs as solicited reports.
PSPs include services involving direct interaction with patients and/or their carers to:
- Help patients manage their medication and/or disease outcomes, including adherence, awareness and education
- Support healthcare professionals in caring for their patients
These programs collect safety information relating to the use of medicinal products.
Patients and carers may report events occurring during the use of a medicinal product that could represent suspected adverse reactions.
How insights from PSPs can help:
- Provide valuable insight into what matters to patients about their condition or treatment
- Identify factors that affect patients’ ability to adhere to treatment and optimise its benefits
- Offer advice and support when patients need medical help, or reassurance to prevent inappropriate treatment discontinuation
- Confirm existing knowledge